Transcriptional analysis of CXCR4, DNMT3A, DNMT3B and DNMT1 gene expression in primary advanced uterine cervical carcinoma

  • Authors:
    • Michał W. Łuczak
    • Andrzej Roszak
    • Piotr Pawlik
    • Helena Kędzia
    • Witold Kędzia
    • Blanka Malkowska-Walczak
    • Margarita Lianeri
    • Paweł P. Jagodziński
  • View Affiliations

  • Published online on: September 1, 2011     https://doi.org/10.3892/ijo.2011.1183
  • Pages: 860-866
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The development of cervical cancer requires genetic and epigenetic factors which result in the persistence of a malignant phenotype. Cervical cancer exhibits also some unique differences from other solid tumors. Normal cervical stratified epithelia have characteristics of hypoxic tissue with over-expression of HIF-1 (hypoxia-inducible factor-1) transcription factor, which targets the transcription of over 70 genes involved in many aspects of cancer biology. One of the genes, which could be induced by HIF-1 is chemokine (C-X-C motif) receptor 4 (CXCR4). CXCR4 could also be epigenetically regulated by methylation of CpG dinucleotides located in the promoter region. Here, we examined the CXCR4, DNMT3A, DNMT3B and DNMT1 transcript levels in cancer tissue (n=30) and non-cancer, normal uterine cervical tissue (n=30) from a Polish cohort. We also compared the methylation status of CXCR4 promoter region in cancer and normal tissue samples. Our result showed significantly higher levels of CXCR4, DNMT3A, DNMT3B and DNMT1 transcript (p=0.0058, 0.0163, 0.0003 and <0.0001, respectively) levels in cancer tissue as compared to normal samples. We did not observe DNA methylation in the CXCR4 promoter region in either control or cancer tissue samples. CXCR4 has a functional hypoxia response element (HRE) in the promoter region, located -1.3 kb from the transcription start site. Our work shows for the first time that HIF-1A could promote the induction of CXCR4 gene expression (Spearman's correlation coefficient = 0.515, p=0.003) in patients with primary advanced uterine cervical carcinoma.

Related Articles

Journal Cover

March 2012
Volume 40 Issue 3

Print ISSN: 1019-6439
Online ISSN:1791-2423

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Łuczak MW, Roszak A, Pawlik P, Kędzia H, Kędzia W, Malkowska-Walczak B, Lianeri M and Jagodziński PP: Transcriptional analysis of CXCR4, DNMT3A, DNMT3B and DNMT1 gene expression in primary advanced uterine cervical carcinoma. Int J Oncol 40: 860-866, 2012
APA
Łuczak, M.W., Roszak, A., Pawlik, P., Kędzia, H., Kędzia, W., Malkowska-Walczak, B. ... Jagodziński, P.P. (2012). Transcriptional analysis of CXCR4, DNMT3A, DNMT3B and DNMT1 gene expression in primary advanced uterine cervical carcinoma. International Journal of Oncology, 40, 860-866. https://doi.org/10.3892/ijo.2011.1183
MLA
Łuczak, M. W., Roszak, A., Pawlik, P., Kędzia, H., Kędzia, W., Malkowska-Walczak, B., Lianeri, M., Jagodziński, P. P."Transcriptional analysis of CXCR4, DNMT3A, DNMT3B and DNMT1 gene expression in primary advanced uterine cervical carcinoma". International Journal of Oncology 40.3 (2012): 860-866.
Chicago
Łuczak, M. W., Roszak, A., Pawlik, P., Kędzia, H., Kędzia, W., Malkowska-Walczak, B., Lianeri, M., Jagodziński, P. P."Transcriptional analysis of CXCR4, DNMT3A, DNMT3B and DNMT1 gene expression in primary advanced uterine cervical carcinoma". International Journal of Oncology 40, no. 3 (2012): 860-866. https://doi.org/10.3892/ijo.2011.1183